BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
Latest, Q2 2026
5,174
Period ended Jun 30, 2026
Change on a year earlier
+37.2%
3,771 in Q2 2025
History
45 quarters
Since Q4 2013
Sources
34
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total shareholders' equity ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 5,174 | +37.2% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 4,760 | +36.0% | Form 10-Q (filed 2026-05-06) ↗ |
| Q4 2025 | Dec 31, 2025 | 4,361 | +30.9% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 30, 2025 | 4,129 | +20.2% | Form 10-Q (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 3,771 | +12.0% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | 3,500 | +4.1% | Form 10-Q (filed 2025-05-07) ↗ |
| Q4 2024 | Dec 31, 2024 | 3,332 | -5.8% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2024 | Sep 30, 2024 | 3,436 | -8.7% | Form 10-Q (filed 2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 3,366 | -11.4% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | 3,360 | -19.2% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 3,537 | -19.3% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | 3,763 | -19.2% | Form 10-Q (filed 2023-11-09) ↗ |
| Q2 2023 | Jun 30, 2023 | 3,799 | -26.9% | Form 10-Q (filed 2023-08-02) ↗ |
| Q1 2023 | Mar 31, 2023 | 4,157 | -28.0% | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2022 | Dec 31, 2022 | 4,383 | -28.5% | Form 10-K (filed 2023-02-27) ↗ |
| Q3 2022 | Sep 30, 2022 | 4,655 | +43.2% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jun 30, 2022 | 5,197 | +47.4% | Form 10-Q (filed 2022-11-09) ↗ |
| Q1 2022 | Mar 31, 2022 | 5,774 | +47.0% | Form 10-Q (filed 2022-11-09) ↗ |
| Q4 2021 | Dec 31, 2021 | 6,133 | +61.2% | Form 10-Q (filed 2022-11-09) ↗ |
| Q3 2021 | Sep 30, 2021 | 3,252 | -24.3% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2021 | Jun 30, 2021 | 3,526 | +38.4% | Form 10-Q (filed 2022-11-09) ↗ |
| Q1 2021 | Mar 31, 2021 | 3,927 | +38.9% | Form 10-Q (filed 2022-11-09) ↗ |
| Q4 2020 | Dec 31, 2020 | 3,803 | +304.4% | Form 10-Q (filed 2022-11-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 4,297 | +232.0% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 2,547 | +62.1% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 31, 2020 | 2,827 | +74.2% | Form 10-Q (filed 2020-05-11) ↗ |
| Q4 2019 | Dec 31, 2019 | 941 | -46.4% | Form 10-K (filed 2023-02-27) ↗ |
| Q3 2019 | Sep 30, 2019 | 1,294 | -34.7% | Form 10-Q (filed 2019-11-12) ↗ |
| Q2 2019 | Jun 30, 2019 | 1,571 | +28.1% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2019 | Mar 31, 2019 | 1,623 | +19.4% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2018 | Dec 31, 2018 | 1,754 | +156.3% | Form 10-K (filed 2019-02-28) ↗ |
| Q3 2018 | Sep 30, 2018 | 1,983 | +159.4% | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2018 | Jun 30, 2018 | 1,227 | +354.0% | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2018 | Mar 31, 2018 | 1,359 | +340.6% | Form 10-Q (filed 2018-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | 684 | +93.9% | Form 10-K (filed 2018-02-28) ↗ |
| Q3 2017 | Sep 30, 2017 | 765 | +307.1% | Form 10-Q (filed 2017-11-13) ↗ |
| Q2 2017 | Jun 30, 2017 | 270 | +22.8% | Form 10-Q (filed 2017-08-09) ↗ |
| Q1 2017 | Mar 31, 2017 | 308 | +26.9% | Form 10-Q (filed 2017-05-10) ↗ |
| Q4 2016 | Dec 31, 2016 | 353 | -446.7% | Form 10-K (filed 2017-03-22) ↗ |
| Q3 2016 | Sep 30, 2016 | 188 | – | Form 10-Q (filed 2016-11-10) ↗ |
| Q2 2016 | Jun 30, 2016 | 220 | – | Form 10-Q (filed 2016-08-10) ↗ |
| Q1 2016 | Mar 31, 2016 | 243 | – | Form 10-Q (filed 2016-05-12) ↗ |
| Q4 2015 | Dec 31, 2015 | -102 | +92.1% | Form 10-Q (filed 2016-05-12) ↗ |
| Q4 2014 | Dec 31, 2014 | -53 | +43.2% | Form 10-K (filed 2017-03-22) ↗ |
| Q4 2013 | Dec 31, 2013 | -37 | – | Form 10-K (filed 2017-03-22) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Total shareholders' equity ($M) ($M), quarterly Q4 2013–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_eq
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.